Home Biotechnology Industry News Stemedica and Scripps to Jointly Investigate Therapeutic Effect of…

Stemedica and Scripps to Jointly Investigate Therapeutic Effect of…

Stemedica Cell Technologies, Inc., a leading manufacturer of adult ischemia tolerant allogeneic stem cells and stem cell factors announced that the Company has signed an agreement with The Scripps...

(PRWeb December 21, 2012)

Read the full story at http://www.prweb.com/releases/stemedica-scripps-ards/stem-cell-factors-sepsis/prweb10263983.htm